Vita Coco (COCO) CEO receives new performance options and stock awards

Rhea-AI Filing Summary

Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported equity awards and updated holdings. He acquired 185,133 performance options at $16.91 per share and 25,945 shares of common stock through restricted stock units granted at $0.00 per share.

The filing notes that the restricted stock units vest in four equal annual installments, with shares automatically withheld at each vesting date to cover tax obligations. A performance-based stock option vested as to 185,133 shares on February 20, 2026 after its performance conditions were satisfied. The report also lists various non-qualified stock option holdings and indirect common stock holdings through family trusts and the reporting person’s spouse.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roper Martin

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A(1)		25,945	A	$0	307,507	D
Common Stock								215,631	I	by Chris Roper FT(2)
Common Stock								216,131	I	by Peter Roper FT(3)
Common Stock								216,131	I	by Thomas Roper FT(4)
Common Stock								41,200	I	by Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Options	$16.91	02/20/2026		A		185,133		02/20/2026	03/10/2033(5)	Stock Option (Right to Buy)	185,133	$16.91	185,133	D
Non-Qualified Stock Option (Right to Buy)	$10.178							(6)	09/19/2029	Common Stock	579,670		579,670	D
Non-Qualified Stock Option (Right to Buy)	$10.178							(6)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (Right to Buy)	$15							(7)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(8)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (Right to Buy)	$26.18							(9)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (Right to Buy)	$32.78							(10)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The Reporting Person was granted restricted stock units that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be withheld to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

2. These shares are held by the Christopher G. Roper Exempt Family Trust.

3. These shares are held by the Peter S. Roper Exempt Family Trust.

4. These shares are held by the Thomas L. Roper Exempt Family Trust.

5. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 185,133 shares on February 20, 2026.

6. The stock option is fully vested and currently exercisable.

7. The stock option vests in four equal annual installments beginning on November 27, 2022.

8. The stock option vests in four equal annual installments beginning on March 10, 2024.

9. The stock option vests in four equal annual installments beginning on March 4, 2025.

10. The stock option vests in four equal annual installments beginning on March 3, 2026.

	/s/ Alison Klein, attorney-in-fact for Martin Roper	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Vita Coco (COCO) report for Martin Roper?

Vita Coco (COCO) reported that CEO Martin Roper acquired performance stock options and restricted stock units. He received 185,133 performance options at $16.91 per share and 25,945 common shares via restricted stock units granted at no cost, along with updated disclosures of existing option and share holdings.

How many performance stock options did Vita Coco (COCO) CEO receive?

The Vita Coco (COCO) CEO was reported as acquiring 185,133 performance stock options. These options relate to a performance-based award whose conditions were satisfied, resulting in vesting of 185,133 shares on February 20, 2026, at an exercise price of $16.91 per share according to the filing.

What restricted stock unit grant did Vita Coco (COCO) disclose for its CEO?

Vita Coco (COCO) disclosed that Martin Roper received 25,945 restricted stock units tied to common stock. The units vest in four equal annual installments on each anniversary of the grant date, and shares will be automatically withheld at vesting to cover tax withholding obligations in non-discretionary transactions.

Were any Vita Coco (COCO) shares sold in this Form 4 filing?

The Form 4 for Vita Coco (COCO) shows no reported share sales by Martin Roper. The transaction summary lists two acquisition transactions and zero sell transactions, indicating activity limited to new awards and vesting events rather than open-market or other disposition sales in this report.

What indirect Vita Coco (COCO) share holdings are reported for Martin Roper?

The filing reports indirect Vita Coco (COCO) common stock holdings through several family trusts and the CEO’s spouse. Shares are held by the Christopher G. Roper, Peter S. Roper, and Thomas L. Roper Exempt Family Trusts, as well as by his spouse, reflecting family-related ownership structures.

How do Vita Coco (COCO) CEO’s performance options vest according to the filing?

The performance stock option for Vita Coco (COCO) CEO vests only if specified performance conditions are met by target dates. The filing states those conditions were timely satisfied, causing vesting of the option as to 185,133 shares on February 20, 2026, while unfulfilled conditions would lead to expiration.